Clinical and biochemical effects of a 3-week program of diet combined with spa therapy in obese and diabetic patients: a pilot open study

International Journal of Biometeorology

Volumn 59, Issue 7, 2015, Pages 783-789

  Fioravanti, Antonella ^a   Adamczyk, Przemysław ^b   Pascarelli, Nicola Antonio ^a   Giannitti, Chiara ^a   Urso, Renato ^a   Tołodziecki, Michał ^c   Ponikowska, Irena ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b Thermal Hospital   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Adipokines; Body mass index; Obesity; Spa therapy; Type 2 diabetes; Weight

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; C REACTIVE PROTEIN; CYTOKINE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN;

ADULT; AGED; BALNEOTHERAPY; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DIET; DIET THERAPY; HUMAN; MALE; MIDDLE AGED; OBESITY; PILOT STUDY; TREATMENT OUTCOME;

ADIPONECTIN; ADULT; AGED; BALNEOLOGY; C-REACTIVE PROTEIN; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; LEPTIN; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84930225547     PISSN: 00207128     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00484-014-0894-5     Document Type: Article

References (39)

1. AL-Suhaimi EA, Shehzad A (2013) Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res 13:12. doi:10.1186/2047-783X-18-12
2. American Diabetes Association (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
3. American Medical Association (2013) Obesity as a disease policy statement. http://www.ama-assn.org/assets/meeting/2013a/a13-addendum-refcomm-d.pdf#page=19
4. Anand SS, Yusuf S (2010) C-reactive protein is a bystander of cardiovascular disease. Eur Heart J 31:2092–2096. doi:10.1093/eurheartj/ehq242
5. Bender T, Karagülle Z, Bálint GP, Gutenbrunner C, Bálint PV, Sukenik S (2005) Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 25:220–224. doi:10.1007/s00296-004-0487-4
6. Cantarini L, Brucato A, Simonini G et al (2013) Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report. Clin Exp Rheumatol 31:207–212
7. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systematic review. Diabetes Metab Res Rev 27:515–527. doi:10.1002/dmrr.1201
8. Deng Y, Scherer PE (2010) Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 1212:E1–E19. doi:10.1111/j.1749-6632.2010.05875.x
9. Development Core Team R (2006) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
10. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919. doi:10.1016/j.jaci.2005.02.023
11. Festa A, D’Agostino RJ, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42–47. doi:10.1161/01.CIR.102.1.42
12. Fioravanti A, Cantarini L, Bacarelli MR, de Lalla A, Ceccatelli L, Blardi P (2011) Effects of spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis. Rheumatol Int 31:879–882. doi:10.1007/s00296-010-1401-x
13. Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430. doi:10.1126/science.1097243
14. Hanh T, Serog P, Fauconnier J, Batailler P, Mercier F, Roques CF, Blin P (2012) One-year effectiveness of a 3-week balneotherapy program for the treatment of overweight or obesity. Evid Based Complement Alternat Med 2012:150839. doi:10.1155/2012/150839
15. Hooper PL (1999) Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 341:924–925. doi:10.1056/NEJM199909163411216
16. Hosseinzadeh-Attar MJ, Golpaie A, Janani L, Derakhshanian H (2013) Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects. Obes Facts 6:193–202. doi:10.1159/000351162
17. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846. doi:10.1038/nature05482
18. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2578–2556. doi:10.1210/jc.2004-0395
19. Komura N, Kihara S, Sonoda M (2008) Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J 72:23–28. doi:10.1253/circj.72.23
20. LeBlanc E, O’Connor E, Whitlock EP, Patnode C, Kapka T (2011) Screening for and management of obesity and overweight in adults. Evidence Synthesis No 89. Rockville MD, Agency for Healthcare Research and Quality, USA
21. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111–2117. doi:10.1172/JCI57132
22. Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B (2008) Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158:179–187. doi:10.1530/EJE-07-0721
23. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS (2000) Diabetes trends in the US: 1990–1998. Diabetes Care 23:1278–1283
24. Montecucco F, Steffens S, Burger F, Pelli G, Monaco C, Mach F (2008) C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes. J Leukoc Biol 84:1109–1119. doi:10.1189/jlb.0208123
25. Ohtsuka Y, Yabunaka N, Watanabe I, Noro H, Agishi Y (1996) Balneotherapy and platelet glutathione metabolism in type II diabetic patients. Int J Biometeorol 39:156–159
26. Oláh M, Koncz Á, Fehér J, Kálmánczhey J, Oláh C, Balogh S, Nagy G, Bender T (2010) The effect of balneotherapy on C-reactive protein, serum cholesterol, triglyceride, total antioxidant status and HSP-60 levels. Int J Biometeorol 54:249–254. doi:10.1007/s00484-009-0276-6
27. Oláh M, Koncz Á, Fehér J, Kálmánczhey J, Oláh C, Nagy G, Bender T (2011) The effect of balneotherapy on antioxidant, inflammatory, and metabolic indices in patients with cardiovascular risk factors (hypertension and obesity)—a randomised, controlled, follow-up study. Contemp Clin Trials 32:793–801. doi:10.1016/j.cct.2011.06.003
28. Petersen KF, Oral EA, Dufour S et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345–1350. doi:10.1172/JCI15001
29. Pinheiro J, Bates D, DebRoy S, Sarkar D, the R Development Core team (2012) Nlme: linear and nonlinear mixed effects models (R Package Version 3.1-103).
30. Punzi L, Ramonda R, Deberg M, Frallonardo P, Campana C, Musacchio E, Henrotin Y (2012) Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthr Cartil 20:557–561. doi:10.1016/j.joca.2012.02.638
31. Reilly JJ, Kelly J (2011) Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes (Lond) 35:891–898. doi:10.1038/ijo.2010.222
32. Revelle W (2013) psych: procedures for personality and psychological research, North Western University, Evanston, Illinois, USA. http://CRAN.R-project.org/package=psych Version = 1.3.2
33. Rolland C, Hession M, Broom L (2011) Effect of weight loss on adipokine levels in obese patients. Diabetes Metab Syndr Obes 4:315–323. doi:10.2147/DMSO.S22788
34. Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122:3415–3422. doi:10.1182/blood-2013-05-427708
35. Shimodozono M, Matsumoto S, Ninomiya K, Miyata R, Ogata A, Etoh S, Watanabe S, Kawahira K (2012) Acute effects of a single warm-water bath on serum adiponectin and leptin levels in healthy men: a pilot study. Int J Biometeorol 56:933–999. doi:10.1007/s00484-011-0502-x
36. Swarbrick M, Stanhope K, Austrheim-Smith I, Van Loan M, Ali M, Wolfe B, Havel PJ (2008) Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 51:1901–1911. doi:10.1007/s00125-008-1118-5
37. WHO (2011) Obesity and overweight. http://www.who.int/ mediacentre/factsheets/fs311/en/index.html.
38. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G (1997) UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 82:654–657
39. Zakynthinos E, Pappa N (2009) Inflammatory biomarkers in coronary artery disease. J Cardiol 53:317–333. doi:10.1016/j.jjcc.2008.12.007